Chitosan Nanoparticles for Pulmonary Delivery of Curcumin/Nintedanib to Treat Pulmonary Fibrosis
These findings highlight the great potential of chitosan-based nanoparticles as a therapeutic strategy for treating IPF and related pulmonary fibrosis with pulmonary delivery pathways.
Authors
- Qingliang Yang (ORCID: https://orcid.org/0000-0002-6905-8484)
- Mengya Jin (ORCID: https://orcid.org/0009-0007-6068-4490)
- Yue He (ORCID: https://orcid.org/0000-0003-2105-5249)
- Shaoqin He (ORCID: https://orcid.org/0009-0008-7610-5139)
- Jinming Liu (ORCID: https://orcid.org/0000-0002-4313-5816)
- Gensheng Yang
- Mengliu Shao
Institutions
- Zhejiang Provincial People's Hospital (CN)
- Zhejiang University of Technology (CN)
Publication Details
- Journal
- International Journal of Nanomedicine
- Published
- 2025-10-01
- DOI
- https://doi.org/10.2147/ijn.s522929
- Primary Topic
- Curcumin's Biomedical Applications
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Natural Science Foundation of Zhejiang Province